Uterine cancer is the most common and second deadliest gynecologic cancer in the US, with 65 950 new cases and 12 550 deaths expected in 2022.
1 Endometrioid carcinoma is the predominant histologic subtype, accounting for approximately 75% of all cases that are usually diagnosed at an early stage with good prognosis.
2 These tumors are associated with obesity as well as hormonal and reproductive factors related to cumulative lifetime estrogen exposure.
3,4 Nonendometrioid carcinomas account for approximately 15% to 20% of cases, have been described as estrogen independent,
3,4 and are typically diagnosed at later stages with poorer prognosis.
2,5 Uterine sarcomas are rare tumors that usually arise in the myometrium and are less well understood.
2